Hizentra (2020-01-16)
Hizentra Recall Summary Hizentra, an intravenous immunoglobulin medication, was recalled in Canada in January 2020 due to product safety concerns. The recall affected all Hizentra products distributed across Canada. This is a Class I recall, indicating a serious safety issue.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-01-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/3452d65e-6430-40fe-a8af-99a143cdd624